Global Dyspnea Treatment Market Size, Status and Forecast 2021-2027

呼吸困難治療の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Dyspnea Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR2025
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:121
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥666,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥889,200見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、呼吸困難治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(治療薬、治療)、用途別市場規模(病院、在宅ケア、専門センター、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・呼吸困難治療の市場動向
・企業の競争状況、市場シェア
・呼吸困難治療の種類別市場規模(治療薬、治療)
・呼吸困難治療の用途別市場規模(病院、在宅ケア、専門センター、その他)
・呼吸困難治療の北米市場規模2016-2027(アメリカ、カナダ)
・呼吸困難治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・呼吸困難治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・呼吸困難治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・呼吸困難治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Mayne Pharma Group Limited、Teva Pharmaceutical Industries Ltd、GlaxoSmithKline Plc、Bausch Health、Hikma Pharmaceuticals plc、Lannett Company, Inc、Amneal Pharmaceuticals LLC、Viatris、Lupin Limited、Akorn Inc、ANI Pharmaceuticals, Inc、Pfizer, Inc、Sun Pharmaceutical Industries Ltd、Nephron Pharmaceuticals Corporation、Aurobindo Pharma、Boehringer Ingelheim International GmbH)
・結論

Dyspnea can be defined as shortness of breath, also known as air hunger. The shortness of breath can range between mild to temporary and serious and long lasting. Dyspnea can be caused due to spending time on high altitudes, overexertion, or as a symptom of a range of other conditions.Signs of dyspnea include shortness of breath due to exertion or due to a medical condition; labored breathing, rapid shallow breathing, heart palpitations, wheezing, coughing, tightness in the chest, and suffocation as a result of breathing difficulties

Market Analysis and Insights: Global Dyspnea Treatment Market
The global Dyspnea Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dyspnea Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dyspnea Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dyspnea Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dyspnea Treatment market.

Global Dyspnea Treatment Scope and Market Size
Dyspnea Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dyspnea Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
by Treatment
Drugs
Therapy
by Route of Administration
Oral
Inhalation
Others

Segment by Application
Hospitals
Home Care
Specialty Centers
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Mayne Pharma Group Limited
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline Plc
Bausch Health
Hikma Pharmaceuticals plc
Lannett Company, Inc
Amneal Pharmaceuticals LLC
Viatris
Lupin Limited
Akorn Inc
ANI Pharmaceuticals, Inc
Pfizer, Inc
Sun Pharmaceutical Industries Ltd
Nephron Pharmaceuticals Corporation
Aurobindo Pharma
Boehringer Ingelheim International GmbH

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dyspnea Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drugs
1.2.3 Therapy
1.3 Market by Application
1.3.1 Global Dyspnea Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Home Care
1.3.4 Specialty Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Dyspnea Treatment Market Perspective (2016-2027)
2.2 Dyspnea Treatment Growth Trends by Regions
2.2.1 Dyspnea Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dyspnea Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Dyspnea Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Dyspnea Treatment Industry Dynamic
2.3.1 Dyspnea Treatment Market Trends
2.3.2 Dyspnea Treatment Market Drivers
2.3.3 Dyspnea Treatment Market Challenges
2.3.4 Dyspnea Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Dyspnea Treatment Players by Revenue
3.1.1 Global Top Dyspnea Treatment Players by Revenue (2016-2021)
3.1.2 Global Dyspnea Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Dyspnea Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dyspnea Treatment Revenue
3.4 Global Dyspnea Treatment Market Concentration Ratio
3.4.1 Global Dyspnea Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dyspnea Treatment Revenue in 2020
3.5 Dyspnea Treatment Key Players Head office and Area Served
3.6 Key Players Dyspnea Treatment Product Solution and Service
3.7 Date of Enter into Dyspnea Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Dyspnea Treatment Breakdown Data by Type
4.1 Global Dyspnea Treatment Historic Market Size by Type (2016-2021)
4.2 Global Dyspnea Treatment Forecasted Market Size by Type (2022-2027)

5 Dyspnea Treatment Breakdown Data by Application
5.1 Global Dyspnea Treatment Historic Market Size by Application (2016-2021)
5.2 Global Dyspnea Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Dyspnea Treatment Market Size (2016-2027)
6.2 North America Dyspnea Treatment Market Size by Type
6.2.1 North America Dyspnea Treatment Market Size by Type (2016-2021)
6.2.2 North America Dyspnea Treatment Market Size by Type (2022-2027)
6.2.3 North America Dyspnea Treatment Market Size by Type (2016-2027)
6.3 North America Dyspnea Treatment Market Size by Application
6.3.1 North America Dyspnea Treatment Market Size by Application (2016-2021)
6.3.2 North America Dyspnea Treatment Market Size by Application (2022-2027)
6.3.3 North America Dyspnea Treatment Market Size by Application (2016-2027)
6.4 North America Dyspnea Treatment Market Size by Country
6.4.1 North America Dyspnea Treatment Market Size by Country (2016-2021)
6.4.2 North America Dyspnea Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Dyspnea Treatment Market Size (2016-2027)
7.2 Europe Dyspnea Treatment Market Size by Type
7.2.1 Europe Dyspnea Treatment Market Size by Type (2016-2021)
7.2.2 Europe Dyspnea Treatment Market Size by Type (2022-2027)
7.2.3 Europe Dyspnea Treatment Market Size by Type (2016-2027)
7.3 Europe Dyspnea Treatment Market Size by Application
7.3.1 Europe Dyspnea Treatment Market Size by Application (2016-2021)
7.3.2 Europe Dyspnea Treatment Market Size by Application (2022-2027)
7.3.3 Europe Dyspnea Treatment Market Size by Application (2016-2027)
7.4 Europe Dyspnea Treatment Market Size by Country
7.4.1 Europe Dyspnea Treatment Market Size by Country (2016-2021)
7.4.2 Europe Dyspnea Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Dyspnea Treatment Market Size (2016-2027)
8.2 Asia-Pacific Dyspnea Treatment Market Size by Type
8.2.1 Asia-Pacific Dyspnea Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dyspnea Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dyspnea Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Dyspnea Treatment Market Size by Application
8.3.1 Asia-Pacific Dyspnea Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dyspnea Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dyspnea Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Dyspnea Treatment Market Size by Region
8.4.1 Asia-Pacific Dyspnea Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dyspnea Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Dyspnea Treatment Market Size (2016-2027)
9.2 Latin America Dyspnea Treatment Market Size by Type
9.2.1 Latin America Dyspnea Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Dyspnea Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Dyspnea Treatment Market Size by Type (2016-2027)
9.3 Latin America Dyspnea Treatment Market Size by Application
9.3.1 Latin America Dyspnea Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Dyspnea Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Dyspnea Treatment Market Size by Application (2016-2027)
9.4 Latin America Dyspnea Treatment Market Size by Country
9.4.1 Latin America Dyspnea Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Dyspnea Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Dyspnea Treatment Market Size (2016-2027)
10.2 Middle East & Africa Dyspnea Treatment Market Size by Type
10.2.1 Middle East & Africa Dyspnea Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dyspnea Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dyspnea Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Dyspnea Treatment Market Size by Application
10.3.1 Middle East & Africa Dyspnea Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dyspnea Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dyspnea Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Dyspnea Treatment Market Size by Country
10.4.1 Middle East & Africa Dyspnea Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dyspnea Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Mayne Pharma Group Limited
11.1.1 Mayne Pharma Group Limited Company Details
11.1.2 Mayne Pharma Group Limited Business Overview
11.1.3 Mayne Pharma Group Limited Dyspnea Treatment Introduction
11.1.4 Mayne Pharma Group Limited Revenue in Dyspnea Treatment Business (2016-2021)
11.1.5 Mayne Pharma Group Limited Recent Development
11.2 Teva Pharmaceutical Industries Ltd
11.2.1 Teva Pharmaceutical Industries Ltd Company Details
11.2.2 Teva Pharmaceutical Industries Ltd Business Overview
11.2.3 Teva Pharmaceutical Industries Ltd Dyspnea Treatment Introduction
11.2.4 Teva Pharmaceutical Industries Ltd Revenue in Dyspnea Treatment Business (2016-2021)
11.2.5 Teva Pharmaceutical Industries Ltd Recent Development
11.3 GlaxoSmithKline Plc
11.3.1 GlaxoSmithKline Plc Company Details
11.3.2 GlaxoSmithKline Plc Business Overview
11.3.3 GlaxoSmithKline Plc Dyspnea Treatment Introduction
11.3.4 GlaxoSmithKline Plc Revenue in Dyspnea Treatment Business (2016-2021)
11.3.5 GlaxoSmithKline Plc Recent Development
11.4 Bausch Health
11.4.1 Bausch Health Company Details
11.4.2 Bausch Health Business Overview
11.4.3 Bausch Health Dyspnea Treatment Introduction
11.4.4 Bausch Health Revenue in Dyspnea Treatment Business (2016-2021)
11.4.5 Bausch Health Recent Development
11.5 Hikma Pharmaceuticals plc
11.5.1 Hikma Pharmaceuticals plc Company Details
11.5.2 Hikma Pharmaceuticals plc Business Overview
11.5.3 Hikma Pharmaceuticals plc Dyspnea Treatment Introduction
11.5.4 Hikma Pharmaceuticals plc Revenue in Dyspnea Treatment Business (2016-2021)
11.5.5 Hikma Pharmaceuticals plc Recent Development
11.6 Lannett Company, Inc
11.6.1 Lannett Company, Inc Company Details
11.6.2 Lannett Company, Inc Business Overview
11.6.3 Lannett Company, Inc Dyspnea Treatment Introduction
11.6.4 Lannett Company, Inc Revenue in Dyspnea Treatment Business (2016-2021)
11.6.5 Lannett Company, Inc Recent Development
11.7 Amneal Pharmaceuticals LLC
11.7.1 Amneal Pharmaceuticals LLC Company Details
11.7.2 Amneal Pharmaceuticals LLC Business Overview
11.7.3 Amneal Pharmaceuticals LLC Dyspnea Treatment Introduction
11.7.4 Amneal Pharmaceuticals LLC Revenue in Dyspnea Treatment Business (2016-2021)
11.7.5 Amneal Pharmaceuticals LLC Recent Development
11.8 Viatris
11.8.1 Viatris Company Details
11.8.2 Viatris Business Overview
11.8.3 Viatris Dyspnea Treatment Introduction
11.8.4 Viatris Revenue in Dyspnea Treatment Business (2016-2021)
11.8.5 Viatris Recent Development
11.9 Lupin Limited
11.9.1 Lupin Limited Company Details
11.9.2 Lupin Limited Business Overview
11.9.3 Lupin Limited Dyspnea Treatment Introduction
11.9.4 Lupin Limited Revenue in Dyspnea Treatment Business (2016-2021)
11.9.5 Lupin Limited Recent Development
11.10 Akorn Inc
11.10.1 Akorn Inc Company Details
11.10.2 Akorn Inc Business Overview
11.10.3 Akorn Inc Dyspnea Treatment Introduction
11.10.4 Akorn Inc Revenue in Dyspnea Treatment Business (2016-2021)
11.10.5 Akorn Inc Recent Development
11.11 ANI Pharmaceuticals, Inc
11.11.1 ANI Pharmaceuticals, Inc Company Details
11.11.2 ANI Pharmaceuticals, Inc Business Overview
11.11.3 ANI Pharmaceuticals, Inc Dyspnea Treatment Introduction
11.11.4 ANI Pharmaceuticals, Inc Revenue in Dyspnea Treatment Business (2016-2021)
11.11.5 ANI Pharmaceuticals, Inc Recent Development
11.12 Pfizer, Inc
11.12.1 Pfizer, Inc Company Details
11.12.2 Pfizer, Inc Business Overview
11.12.3 Pfizer, Inc Dyspnea Treatment Introduction
11.12.4 Pfizer, Inc Revenue in Dyspnea Treatment Business (2016-2021)
11.12.5 Pfizer, Inc Recent Development
11.13 Sun Pharmaceutical Industries Ltd
11.13.1 Sun Pharmaceutical Industries Ltd Company Details
11.13.2 Sun Pharmaceutical Industries Ltd Business Overview
11.13.3 Sun Pharmaceutical Industries Ltd Dyspnea Treatment Introduction
11.13.4 Sun Pharmaceutical Industries Ltd Revenue in Dyspnea Treatment Business (2016-2021)
11.13.5 Sun Pharmaceutical Industries Ltd Recent Development
11.14 Nephron Pharmaceuticals Corporation
11.14.1 Nephron Pharmaceuticals Corporation Company Details
11.14.2 Nephron Pharmaceuticals Corporation Business Overview
11.14.3 Nephron Pharmaceuticals Corporation Dyspnea Treatment Introduction
11.14.4 Nephron Pharmaceuticals Corporation Revenue in Dyspnea Treatment Business (2016-2021)
11.14.5 Nephron Pharmaceuticals Corporation Recent Development
11.15 Aurobindo Pharma
11.15.1 Aurobindo Pharma Company Details
11.15.2 Aurobindo Pharma Business Overview
11.15.3 Aurobindo Pharma Dyspnea Treatment Introduction
11.15.4 Aurobindo Pharma Revenue in Dyspnea Treatment Business (2016-2021)
11.15.5 Aurobindo Pharma Recent Development
11.16 Boehringer Ingelheim International GmbH
11.16.1 Boehringer Ingelheim International GmbH Company Details
11.16.2 Boehringer Ingelheim International GmbH Business Overview
11.16.3 Boehringer Ingelheim International GmbH Dyspnea Treatment Introduction
11.16.4 Boehringer Ingelheim International GmbH Revenue in Dyspnea Treatment Business (2016-2021)
11.16.5 Boehringer Ingelheim International GmbH Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Dyspnea Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drugs
Table 3. Key Players of Therapy
Table 4. Global Dyspnea Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Dyspnea Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Dyspnea Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Dyspnea Treatment Market Share by Regions (2016-2021)
Table 8. Global Dyspnea Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Dyspnea Treatment Market Share by Regions (2022-2027)
Table 10. Dyspnea Treatment Market Trends
Table 11. Dyspnea Treatment Market Drivers
Table 12. Dyspnea Treatment Market Challenges
Table 13. Dyspnea Treatment Market Restraints
Table 14. Global Dyspnea Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Dyspnea Treatment Market Share by Players (2016-2021)
Table 16. Global Top Dyspnea Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dyspnea Treatment as of 2020)
Table 17. Ranking of Global Top Dyspnea Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Dyspnea Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Dyspnea Treatment Product Solution and Service
Table 21. Date of Enter into Dyspnea Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Dyspnea Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Dyspnea Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Dyspnea Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Dyspnea Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Dyspnea Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Dyspnea Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Dyspnea Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Dyspnea Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Dyspnea Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Dyspnea Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Dyspnea Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Dyspnea Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Dyspnea Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Dyspnea Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Dyspnea Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Dyspnea Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Dyspnea Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Dyspnea Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Dyspnea Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Dyspnea Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Dyspnea Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Dyspnea Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Dyspnea Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Dyspnea Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Dyspnea Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Dyspnea Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Dyspnea Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Dyspnea Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Dyspnea Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Dyspnea Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Dyspnea Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Dyspnea Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Dyspnea Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Dyspnea Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Dyspnea Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Dyspnea Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Dyspnea Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Dyspnea Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Mayne Pharma Group Limited Company Details
Table 62. Mayne Pharma Group Limited Business Overview
Table 63. Mayne Pharma Group Limited Dyspnea Treatment Product
Table 64. Mayne Pharma Group Limited Revenue in Dyspnea Treatment Business (2016-2021) & (US$ Million)
Table 65. Mayne Pharma Group Limited Recent Development
Table 66. Teva Pharmaceutical Industries Ltd Company Details
Table 67. Teva Pharmaceutical Industries Ltd Business Overview
Table 68. Teva Pharmaceutical Industries Ltd Dyspnea Treatment Product
Table 69. Teva Pharmaceutical Industries Ltd Revenue in Dyspnea Treatment Business (2016-2021) & (US$ Million)
Table 70. Teva Pharmaceutical Industries Ltd Recent Development
Table 71. GlaxoSmithKline Plc Company Details
Table 72. GlaxoSmithKline Plc Business Overview
Table 73. GlaxoSmithKline Plc Dyspnea Treatment Product
Table 74. GlaxoSmithKline Plc Revenue in Dyspnea Treatment Business (2016-2021) & (US$ Million)
Table 75. GlaxoSmithKline Plc Recent Development
Table 76. Bausch Health Company Details
Table 77. Bausch Health Business Overview
Table 78. Bausch Health Dyspnea Treatment Product
Table 79. Bausch Health Revenue in Dyspnea Treatment Business (2016-2021) & (US$ Million)
Table 80. Bausch Health Recent Development
Table 81. Hikma Pharmaceuticals plc Company Details
Table 82. Hikma Pharmaceuticals plc Business Overview
Table 83. Hikma Pharmaceuticals plc Dyspnea Treatment Product
Table 84. Hikma Pharmaceuticals plc Revenue in Dyspnea Treatment Business (2016-2021) & (US$ Million)
Table 85. Hikma Pharmaceuticals plc Recent Development
Table 86. Lannett Company, Inc Company Details
Table 87. Lannett Company, Inc Business Overview
Table 88. Lannett Company, Inc Dyspnea Treatment Product
Table 89. Lannett Company, Inc Revenue in Dyspnea Treatment Business (2016-2021) & (US$ Million)
Table 90. Lannett Company, Inc Recent Development
Table 91. Amneal Pharmaceuticals LLC Company Details
Table 92. Amneal Pharmaceuticals LLC Business Overview
Table 93. Amneal Pharmaceuticals LLC Dyspnea Treatment Product
Table 94. Amneal Pharmaceuticals LLC Revenue in Dyspnea Treatment Business (2016-2021) & (US$ Million)
Table 95. Amneal Pharmaceuticals LLC Recent Development
Table 96. Viatris Company Details
Table 97. Viatris Business Overview
Table 98. Viatris Revenue in Dyspnea Treatment Business (2016-2021) & (US$ Million)
Table 99. Viatris Recent Development
Table 100. Lupin Limited Company Details
Table 101. Lupin Limited Business Overview
Table 102. Lupin Limited Dyspnea Treatment Product
Table 103. Lupin Limited Revenue in Dyspnea Treatment Business (2016-2021) & (US$ Million)
Table 104. Lupin Limited Recent Development
Table 105. Akorn Inc Company Details
Table 106. Akorn Inc Business Overview
Table 107. Akorn Inc Dyspnea Treatment Product
Table 108. Akorn Inc Revenue in Dyspnea Treatment Business (2016-2021) & (US$ Million)
Table 109. Akorn Inc Recent Development
Table 110. ANI Pharmaceuticals, Inc Company Details
Table 111. ANI Pharmaceuticals, Inc Business Overview
Table 112. ANI Pharmaceuticals, Inc Dyspnea Treatment Product
Table 113. ANI Pharmaceuticals, Inc Revenue in Dyspnea Treatment Business (2016-2021) & (US$ Million)
Table 114. ANI Pharmaceuticals, Inc Recent Development
Table 115. Pfizer, Inc Company Details
Table 116. Pfizer, Inc Business Overview
Table 117. Pfizer, Inc Dyspnea Treatment Product
Table 118. Pfizer, Inc Revenue in Dyspnea Treatment Business (2016-2021) & (US$ Million)
Table 119. Pfizer, Inc Recent Development
Table 120. Sun Pharmaceutical Industries Ltd Company Details
Table 121. Sun Pharmaceutical Industries Ltd Business Overview
Table 122. Sun Pharmaceutical Industries Ltd Dyspnea Treatment Product
Table 123. Sun Pharmaceutical Industries Ltd Revenue in Dyspnea Treatment Business (2016-2021) & (US$ Million)
Table 124. Sun Pharmaceutical Industries Ltd Recent Development
Table 125. Nephron Pharmaceuticals Corporation Company Details
Table 126. Nephron Pharmaceuticals Corporation Business Overview
Table 127. Nephron Pharmaceuticals Corporation Dyspnea Treatment Product
Table 128. Nephron Pharmaceuticals Corporation Revenue in Dyspnea Treatment Business (2016-2021) & (US$ Million)
Table 129. Nephron Pharmaceuticals Corporation Recent Development
Table 130. Aurobindo Pharma Company Details
Table 131. Aurobindo Pharma Business Overview
Table 132. Aurobindo Pharma Dyspnea Treatment Product
Table 133. Aurobindo Pharma Revenue in Dyspnea Treatment Business (2016-2021) & (US$ Million)
Table 134. Aurobindo Pharma Recent Development
Table 135. Boehringer Ingelheim International GmbH Company Details
Table 136. Boehringer Ingelheim International GmbH Business Overview
Table 137. Boehringer Ingelheim International GmbH Dyspnea Treatment Product
Table 138. Boehringer Ingelheim International GmbH Revenue in Dyspnea Treatment Business (2016-2021) & (US$ Million)
Table 139. Boehringer Ingelheim International GmbH Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dyspnea Treatment Market Share by Type: 2020 VS 2027
Figure 2. Drugs Features
Figure 3. Therapy Features
Figure 4. Global Dyspnea Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Home Care Case Studies
Figure 7. Specialty Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Dyspnea Treatment Report Years Considered
Figure 10. Global Dyspnea Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Dyspnea Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Dyspnea Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Dyspnea Treatment Market Share by Regions (2022-2027)
Figure 14. Global Dyspnea Treatment Market Share by Players in 2020
Figure 15. Global Top Dyspnea Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dyspnea Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Dyspnea Treatment Revenue in 2020
Figure 17. Global Dyspnea Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Dyspnea Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Dyspnea Treatment Market Share by Type (2016-2027)
Figure 21. North America Dyspnea Treatment Market Share by Application (2016-2027)
Figure 22. North America Dyspnea Treatment Market Share by Country (2016-2027)
Figure 23. United States Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Dyspnea Treatment Market Share by Type (2016-2027)
Figure 27. Europe Dyspnea Treatment Market Share by Application (2016-2027)
Figure 28. Europe Dyspnea Treatment Market Share by Country (2016-2027)
Figure 29. Germany Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Dyspnea Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Dyspnea Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Dyspnea Treatment Market Share by Region (2016-2027)
Figure 39. China Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Dyspnea Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Dyspnea Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Dyspnea Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Dyspnea Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Dyspnea Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Dyspnea Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Dyspnea Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Mayne Pharma Group Limited Revenue Growth Rate in Dyspnea Treatment Business (2016-2021)
Figure 59. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Dyspnea Treatment Business (2016-2021)
Figure 60. GlaxoSmithKline Plc Revenue Growth Rate in Dyspnea Treatment Business (2016-2021)
Figure 61. Bausch Health Revenue Growth Rate in Dyspnea Treatment Business (2016-2021)
Figure 62. Hikma Pharmaceuticals plc Revenue Growth Rate in Dyspnea Treatment Business (2016-2021)
Figure 63. Lannett Company, Inc Revenue Growth Rate in Dyspnea Treatment Business (2016-2021)
Figure 64. Amneal Pharmaceuticals LLC Revenue Growth Rate in Dyspnea Treatment Business (2016-2021)
Figure 65. Viatris Revenue Growth Rate in Dyspnea Treatment Business (2016-2021)
Figure 66. Lupin Limited Revenue Growth Rate in Dyspnea Treatment Business (2016-2021)
Figure 67. Akorn Inc Revenue Growth Rate in Dyspnea Treatment Business (2016-2021)
Figure 68. ANI Pharmaceuticals, Inc Revenue Growth Rate in Dyspnea Treatment Business (2016-2021)
Figure 69. Pfizer, Inc Revenue Growth Rate in Dyspnea Treatment Business (2016-2021)
Figure 70. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Dyspnea Treatment Business (2016-2021)
Figure 71. Nephron Pharmaceuticals Corporation Revenue Growth Rate in Dyspnea Treatment Business (2016-2021)
Figure 72. Aurobindo Pharma Revenue Growth Rate in Dyspnea Treatment Business (2016-2021)
Figure 73. Boehringer Ingelheim International GmbH Revenue Growth Rate in Dyspnea Treatment Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[呼吸困難治療の世界市場規模・現状・予測2021年-2027年] (Global Dyspnea Treatment Market Size, Status and Forecast 2021-2027 / QY21APR2025)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆